Cross Atlantic Partners

Cross Atlantic Partners

Cross Atlantic Partners (CAP) actively manages private equity funds for investment in developing healthcare and life sciences companies.

Cross Atlantic Partners (CAP) is a New York City based venture capital firm. They actively manage private equity funds for investment in developing healthcare and life sciences companies in the United States. They focus on later-stage private and public companies developing innovative drug discovery tools, devices, and services for human healthcare.

Investment

Cross Atlantic Partners has made 13 investments. Their most recent investment was on Jan 8, 2013, when Labcyte raised $5.3M. Other investments include QuesCom, Sapphire Digital, Filao, Mobile Digital Media and GQ Life Sciences.

Cross Atlantic Partners has had 6 exits. Cross Atlantic Partners's most notable exits include Labcyte, Acorda Therapeutics, and GQ Life Sciences.

Timeline

Funded Companies

Company
Industry
Website
Location
Filao
QuesCom
Mobile Digital Media
3 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.